These findings suggest that a reduction in HDAC2 expression occurs before the onset of fibrillar tau pathology and that this alteration is exacerbated by phosphorylated and conformational tau epitopes in nbM neurons during the progression of AD. The gene discussed is MAPT; the disease is Alzheimer disease.